Chang HY - Search Results

1

Molecular and clinical characteristics of hepatitis B virus in Korea.

Ahn SH, Yuen L, Han KH, Littlejohn M, Chang HY, Damerow H, Ayres A, Heo J, Locarnini S, Revill PA. Ahn SH, et al. Among authors: chang hy. J Med Virol. 2010 Jul;82(7):1126-34. doi: 10.1002/jmv.21844. J Med Virol. 2010. PMID: 20513074

2

Immunogenetics of hepatitis B virus infection.

Han KH, Kim KH, Chang HY. Han KH, et al. Among authors: chang hy. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S329-32. doi: 10.1046/j.1440-1746.17.s3.22.x. J Gastroenterol Hepatol. 2002. PMID: 12472958 Review. No abstract available.

3

Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy.

Kim KH, Lee KH, Chang HY, Ahn SH, Tong S, Yoon YJ, Seong BL, Kim SI, Han KH. Kim KH, et al. Among authors: chang hy. J Med Virol. 2003 Nov;71(3):367-75. doi: 10.1002/jmv.10503. J Med Virol. 2003. PMID: 12966541

4

[Reappraisal of HBV genotypes and clinical significance in Koreans using MALDI-TOF mass spectrometry].

Lee JM, Ahn SH, Chang HY, Shin JE, Kim DY, Sim MK, Hong SP, Chung HJ, Kim SO, Han KH, Chon CY, Moon YM. Lee JM, et al. Among authors: chang hy. Korean J Hepatol. 2004 Dec;10(4):260-70. Korean J Hepatol. 2004. PMID: 15613801 Korean.

5

Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.

Ahn SH, Park YN, Park JY, Chang HY, Lee JM, Shin JE, Han KH, Park C, Moon YM, Chon CY. Ahn SH, et al. Among authors: chang hy. J Hepatol. 2005 Feb;42(2):188-94. doi: 10.1016/j.jhep.2004.10.026. J Hepatol. 2005. PMID: 15664243

6

Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization.

Kim HS, Han KH, Ahn SH, Kim EO, Chang HY, Moon MS, Chung HJ, Yoo W, Kim SO, Hong SP. Kim HS, et al. Among authors: chang hy. Antivir Ther. 2005;10(3):441-9. Antivir Ther. 2005. PMID: 15918335

7

[Association between CCR5 promoter polymorphisms and hepatitis B virus infection].

Chang HY, Ahn SH, Kim DY, Shin JS, Kim YS, Hong SP, Chung HJ, Kim SO, Yoo WD, Han KH. Chang HY, et al. Korean J Hepatol. 2005 Jun;11(2):116-24. Korean J Hepatol. 2005. PMID: 15980670 Korean.

8

Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea.

Ahn SH, Kim DY, Chang HY, Hong SP, Shin JS, Kim YS, Kim H, Kim JK, Paik YH, Lee KS, Chon CY, Moon YM, Han KH. Ahn SH, et al. Among authors: chang hy. J Med Virol. 2006 Dec;78(12):1564-71. doi: 10.1002/jmv.20739. J Med Virol. 2006. PMID: 17063508

9

MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Yoon YJ, Chang HY, Ahn SH, Kim JK, Park YK, Kang DR, Park JY, Myoung SM, Kim DY, Chon CY, Han KH. Yoon YJ, et al. Among authors: chang hy. Carcinogenesis. 2008 Jun;29(6):1192-6. doi: 10.1093/carcin/bgn090. Epub 2008 Apr 4. Carcinogenesis. 2008. PMID: 18390844 Free article.

10

Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.

Lee HW, Lee JI, Um SH, Ahn SH, Chang HY, Park YK, Hong SP, Moon YM, Han KH. Lee HW, et al. Among authors: chang hy. J Gastroenterol Hepatol. 2008 May;23(5):729-35. doi: 10.1111/j.1440-1746.2008.05387.x. J Gastroenterol Hepatol. 2008. PMID: 18410608 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,161 results

Search Page

Filters